Background-Scavenger receptor class B type 1 (SCARB1) plays an important role in high-density lipoprotein cholesterol (HDL-C) metabolism in selective cholesteryl ester uptake and in free cholesterol cellular efflux. Methods and Results-This study aims to identify common (minor allele frequency ≥5%) and low-frequency/rare (minor allele frequency <5%) variants, using resequencing all 13 exons and exon-intron boundaries of SCARB1 in 95 individuals with extreme HDL-C levels selected from a population-based sample of 623 US non-Hispanic whites. The sequencing step identified 44 variants, of which 11 were novel with minor allele frequency <1%. Seventy-six variants (40 sequence variants, 32 common HapMap tag single nucleotide polymorphisms, and 4 relevant variants) were selected for genotyping in the total sample of 623 subjects followed by association analyses with lipid traits. Seven variants were nominally associated with apolipoprotein B (apoB; n=4) or HDL-C (n=3; P<0.05). Three variants associated with apoB remained significant after controlling false discovery rate. The most significant association was observed between rs4765615 and apoB (P=0.0059), while rs11057844 showed the strongest association with HDL-C (P=0.0035). A set of 17 rare variants (minor allele frequency ≤1%) showed significant association with apoB (P=0.0284). Haplotype analysis revealed 4 regions significantly associated with either apoB or HDL-C. Conclusions-Our findings provide new information about the genetic role of SCARB1 in affecting plasma apoB levels in addition to its established role in HDL-C metabolism. (Circ Cardiovasc Genet. 2014;7:838-847.)
T he inverse association between high-density lipoprotein cholesterol (HDL-C) and the risk of coronary heart disease (CHD) has been widely acknowledged. 1 Raising the levels of HDL-C is among the targets for a reduced risk of CHD in addition to lowering the levels of low-density lipoprotein cholesterol (LDL-C). 2 Genetic contribution to plasma lipid and lipoprotein levels has been indicated because of the high heritability of lipid traits. 3 Genomewide association studies have identified many candidate genes involved in lipid metabolism where common variants are associated with plasma lipoprotein-lipid levels. 4, 5 However, most of these reported variants are nonfunctional with small genetic effects on lipoprotein-lipid variation. 6 Focus on extreme phenotypic distribution has been suggested to discover disease-associated functional variants, including low-frequency (LF)/rare variants (minor allele frequency [MAF]<5%) for complex traits. 7 Sequencing candidate genes in individuals with extreme lipid levels have highlighted the important role of LF/rare variants in lipid metabolism. 8, 9 
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Scavenger receptor class B type 1 (SCARB1, protein; SCARB1, gene) is a multiligand receptor involved in the regulation of HDL-C metabolism, mainly in reverse cholesterol transport. 10 SCARB1 has a high affinity for binding to HDL-C and is abundantly expressed in liver and steroidogenic tissues. 11 SCARB1 mediates the selective cholesteryl ester uptake from HDL particles and promotes the bidirectional cellular flux of free cholesterol between cells and HDL-C. SCARB1 is also implicated in the metabolism of apolipoprotein B (apoB)-containing lipoproteins. 12, 13 SCARB1 is encoded by the SCARB1 gene (human gene ID 949) located on chromosome 12q24.31, spanning 86.3kb span. Several genetic studies in various populations have discovered multiple SCARB1 variants and reported their relationship with lipid traits 4, [14] [15] [16] [17] and subclinical atherosclerosis and incidence of CHD. 18 However, the role of SCARB1 LF/rare variants in relation to lipoprotein-lipid levels has not been studied. In this study, we have tested the hypothesis that both common and LF/rare SCARB1 variants have significant impact on plasma lipoprotein-lipid variation in the general population. We have resequenced all 13 exons and their exon-intron boundaries of SCARB1 in 95 non-Hispanic white (NHW) individuals having extreme HDL-C levels to identify both common (MAF≥5%) and LF/rare (MAF<5%) variants. We then genotyped selected identified variants plus common HapMap tag single nucleotide polymorphisms (SNPs) in the total sample of 623 NHWs followed by genotype-phenotype association analyses with HDL-C, LDL-C, triglycerides (TG), and apoB levels.
Methods

Subjects
The study was performed on a well-characterized epidemiological sample of 623 NHW nondiabetic subjects that were originally recruited as part of the San Luis Valley Diabetes Study in southern Colorado. 19 The subjects were between the ages of 24 and 75 years who had a normal response to a standard oral glucose test. The main characteristics for 623 NHWs used in this study are given in Table I in the onlineonly Data Supplement. All subjects provided written informed consent. The study protocol was approved by the University of Pittsburgh and University of Colorado Denver Institutional Review Boards.
Selected Samples for Resequencing
Ninety-five individuals with extreme HDL-C levels falling in the upper and lower 10th percentile were selected from the total sample of 623 NHWs for resequencing. There were 47 individuals in the high HDL-C group (HDL-C ≥90th percentile, range: 58-106 mg/dL) and 48 individuals in the low HDL-C group (HDL-C ≤10th percentile, range: 20-40 mg/dL; Table II in the online-only Data Supplement).
Lipid Measurements
Blood samples were collected after ≥8 hours of fasting and immediately placed on ice. Plasma was separated by centrifugation at 4°C and then stored at −80°C before the measurement of total cholesterol, HDL-C, and TG within 30 days in the General Clinical Research Laboratory of the University of Colorado Health Sciences Center, which is certified by the College of American Pathologists for determination of lipid levels. 19 Total cholesterol and TG were measured by standardized enzymatic assays, and HDL-C was determined by dextran sulfate magnesium precipitation. 19 LDL-C was calculated with the Friedewald formula 20 when TG levels were <400 mg/dL. One of the plasma aliquots, stored at −80°C and never thawed, was used to determine apoB levels on a subset of the total sample (n=425) using the Boehringer Mannheim Turbidimetric procedure at the University of Pittsburgh Heinz Nutrition Laboratory certified by the Clinical Laboratory Improvement Amendments. 21 The routine coefficient of variations between runs were 3.5% for total cholesterol, 4.0% for HDL-C, 3.7% for TG, and 3.3% for apoB.
DNA Sample Preparations and Sequencing
Genomic DNA was extracted from leukocytes using a standard DNA extraction protocol. Sequencing samples were amplified into multiple fragments with specific designed primers via polymerase chain reaction (PCR Table III in the online-only Data Supplement for primers and PCR fragment sizes). PCR reactions and cycling conditions are available upon requests.
Sequencing reactions were performed following the manufacturer's protocols and conducted on the Applied Biosystems 3730xl DNA Analyzer (Beckman Coulter Genomics, Danvers, MA). Sequencing variants were reviewed and analyzed using Variant Reporter (version 1.0, Applied Biosystems, Foster City, CA) and Sequencher (version 4.8, Gene Codes Corporation, Ann Arbor, MI) programs.
Variant Selection for Genotyping
Common tagSNPs (MAF≥5%) from our sequencing data were selected by running Tagger analysis using Haploview (Broad Institute of MIT and Harvard, Cambridge, MA, http://www.broadinstitute. org/) with an r 2 cutoff of 0.90. 22 Because our sequencing was focused only on the coding regions and exon-intron boundaries, we selected common tagSNPs (MAF≥5%) covering the entire SCARB1 gene and 1 kb of each of 5′ and 3′ flanking regions from the HapMap data (release #27, genome build 36, dbSNP build 126) for the CEU (Utah residents with northern and western European ancestry) using Tagger analysis with an r 2 threshold of 0.80 for genotyping in our sample ( Table IV in the online-only Data Supplement; Figure I in the online-only Data Supplement). In addition, we also selected 4 reported SCARB1 variants to be associated with lipid profile for genotyping, irrespective of their linkage disequilibrium (LD) pattern with other selected variants. Altogether, we selected 76 variants for genotyping in a total of 623 NHW subjects as follows: 40 variants identified by sequencing (8 common tagSNPs and 32 LF/rare variants), 32 common HapMap-CEU tagSNPs, and 4 relevant associated variants from the literatures ( Table V in 
Genotyping
Genotyping was performed using either Sequenom iPLEX Assay (Sequenom, Inc., San Diego, CA) at the Genomics and Proteomics Core Laboratories, University of Pittsburgh (http://www.genetics. pitt.edu/) or TaqMan SNP Genotyping Assays (Life Technologies Corporation, Grand Island, NY) in our laboratory. Assay reactions were performed according to manufacturers' instructions.
Statistical Analysis
The differences in demographics and lipid profile values between the high and low extreme HDL-C groups were calculated by t test or χ 2 test, depending on types of variables.
Allele frequencies and genotype frequencies of quality controlpassed genotyped variants (n=69) were calculated. The assessment of Hardy-Weinberg equilibrium was performed using the Pearson χ 2 test. None of the study samples had missing genotype data >2%. HDL-C, TG, and apoB variables were Box-Cox transformed to achieve normality before analyses. The outliers falling beyond the range of mean±3.5 SD (standard deviation) were excluded from further analyses. The most parsimonious set of covariates (sex, age, smoking [never, current, or past], and body mass index) specific to each trait was identified using stepwise regression, and then significant covariates for each trait were used for adjustment in all analyses.
Genetic associations between genotyped variants and 4 traits-HDL-C, LDL-C, TG, and apoB-were examined under a linear additive genetic model by coding alleles as follows: major allele homozygote=0, minor allele heterozygote=1, and minor allele ho-mozygote=2. For each variant with MAF≥5% (n=39), the single-site P value of <0.05 was considered as suggestive evidence of association. Because of insufficient power to detect single-site association of variants with MAF<5% (n=30), those with P value <0.05 were interpreted separately. We applied Benjamini-Hochberg procedure 23 to control for false discovery rate (FDR) in single-site analysis for December 2014 each trait and considered an FDR value (q value) of <0.20 as statistically significant.
For LF/rare variants (MAF<5%), we used an optimal sequencing kernel association test (SKAT-O) 24 for analyzing association with lipid traits. SKAT-O provided better statistical power and appropriate assumption on genetic structure in the genetic model for our data than the burden test and the sequence kernel association test. SKAT-O was applied to a total 30 LF/rare variants with MAF<5%, which were categorized into 3 subgroups on the basis of MAF: <5% (n=30), ≤2% (n=20), and ≤1% (n=17). A SKAT-O P value <0.05 of LF/rare variant association was considered being statistically significant.
The haplotype association of 69 variants for 4 lipid traits was estimated using the generalized linear model with a fixed length sliding window-4 variants per window and 1 overlapping variant, as too many variants of each window can result in inefficient and impractical model. A global P value <0.05 was considered significant for overall association of haplotypes with frequency >1%.
The gene-based analysis using the versatile gene-based association software (http://genepi.qimr.edu.au/general/softwaretools.cgi) 25 was conducted to test the combined genetic effect of all successfully genotyped 69 variants on each trait. A P value of <0.05 was considered as gene-based significance. All other analyses were performed in the R statistical software (http://www.r-project.org/).
Results
Identification of SCARB1 Sequence Variants
Sequencing of 95 individuals with extreme HDL-C levels identified a total of 44 variants. Thirty-three of them (75%) were previously identified based on dbSNP build 139 and 11 were novel (submitted to dbSNP database: http://www.ncbi.nlm.nih. gov/SNP/snp_viewTable.cgi?handle=KAMBOH [batch ID: SCARB1_EA]). Of 44 variants, 43 were substitutions and 1 was a deletion ( Table V in the online-only Data Supplement) .
Of 44 variants, 12 (27.27%) had MAF≥5% and 32 (72.73%) had MAF<5% (MAF between 1% and 5%, n=15; MAF≤1%, n=17). Two of the 12 variants with MAF≥5% were coding variants (rs4238001 [Gly2Ser] in exon 1 and rs5888 [Ala350Ala] in exon 8). Among 12 common variants, 2 LD blocks were observed with r 2 ≥0.90 ( Figure II in the online-only Data Supplement). Rs701104 was in perfect LD with rs838883 (r 2 = 1.0), whereas 3 additional variants (rs838884, rs838882, and rs838881) were in strong LD with rs838880 (r 2 ranging from 0.93 to 0.97). Of the 32 LF/rare variants with MAF<5%, 21 are known and the remaining 11 are novel. There were 4 coding variants with MAF<5% (rs73227571 [Tyr92Tyr] in exon 2, rs5891 [Val135Ile] in exon 3, rs201977189 [Gly239Arg] in exon 5, and rs10396214 [Arg484Trp] in exon 13).
Of the 32 LF/rare variants, 13 were present only in the high HDL-C group, including 2 nonsynonymous variants (rs5891 [Val135Ile] and rs201977189 [Gly239Arg]), and 9 were observed only in the low HDL-C group (Table V in the online-only Data Supplement). All 11 novel variants had MAF<1% and were noncoding; 5 and 6 were present in the high and low HDL-C groups, respectively. The proportions of individuals carrying ≥1 LF/rare variant (MAF<5%) between the high and the low HDL-C groups were similar (42.55% versus 37.50%; P=0.615).
Genotyping of SCARB1 Variants
Forty of the 44 sequence variants were selected for genotyping (4 were excluded because of strong LD) in the entire sample. In addition, we selected 32 common HapMap-CEU tagSNPs from the unsequenced SCARB1 intronic regions and 4 variants with reported associations with lipid traits from the literatures. Of the 76 variants selected for genotyping, 69 (MAF≥5%, n=39; MAF between 1% and 5%, n=13; MAF≤1%, n=17) were successfully genotyped in all 623 NHWs (genotype success rate ≥90% and discrepancy rate <1% among 10% of the replication sample), and none deviated from the Hardy-Weinberg equilibrium. Characteristics and LD structure of successfully 69 genotyped variants are shown in Table V in the online-only Data Supplement and Figure III in the online-only Data Supplement.
Of 69 variants, 58 (84.05%) were located in introns, 8 (11.60%) in exons, and 3 (4.35%) in 3′ flanking region ( Table  VI in the online-only Data Supplement; Figure IV in the online-only Data Supplement). The most numbers of genotyped variants (n=25) were present in the longest intron 1. Of the 11 newly identified sequence variants, only 8 were successfully genotyped (Table VII) 
Associations of SCARB1 Variants With Lipid Traits
Gene-Based Association
Initially, we performed a gene-based test including all successfully genotyped 69 variants (Table 1 ) and found a nominal association with apoB (P=0.0425; best SNP p78334-chr12_125271186, P=0.0015) and a borderline association with HDL-C (P=0.132; best SNP rs11057844, P=0.0035).
Association of Common Variants
Single-locus association analysis of 39 common variants (MAF≥5%) revealed 7 nominal associations (P<0.05), including 3 with HDL-C (rs11057844, rs701106, and rs838880) and 4 with apoB (rs2343394, rs4765615, rs2278986, and rs11057820). Of these 7 variants with nominal association, 3 associated with apoB (rs2343394, rs4765615, and rs2278986) remained significant after multiple testing adjustment (FDR <0.20; Tables VIII and IX in the online-only Data Supplement). No significant associations were observed with either LDL-C or TG (Tables X and XI in the online-only Data  Supplement) .
Of the 3 nominally associated variants with HDL-C, the strongest signal was observed with rs11057844 (β=−0.0395; P=0.0035; FDR=0.227) followed by rs701106 (β=0.0394; P=0.0066; FDR=0.227) and rs838880 (β=0.0257; P=0.025; FDR=0.457; Table 2 ). The lead variant, rs11077844, was not correlated with the other 2 (r 2 =0). Whereas rs701106 and rs838880 were in modest LD with each other (r 2 =0.37; Figure 1 ). The 4 apoB-associated variants had an elevating effect on apoB levels: rs2343394 (β=1.2544; P=0.0082; FDR=0.165), rs4765615 (β=1.2493; P=0.0059; FDR=0.165), rs2278986 (β=1.1926; P=0.0122; FDR=0.165), and rs11057820 (β=0.87; P=0.0436; FDR=0.430; Table 2 ). Among the 3 apoB-associated variants with similar effects and FDR-significance, 2 (rs2343394 and rs2278986) were in strong LD (r 2 =0.94) and together they were in moderate LD with rs4765615 (r 2 =0.46-0.48; Figure 1 ).
Association of LF/Rare Variants
A total of 30 LF/rare variants with MAF<5% were tested for association using SKAT-O at 3 different MAF thresholds (<5%, ≤2%, and ≤1%). The group of 17 rare variants with MAF≤1% showed significant association with apoB (P=0.0284; Table 3 ). Next, we examined the distribution of lipid traits among variants with MAF≤1% to determine whether some of them were associated with extreme lipid phenotypes. We found 4 variants that were detected in ≥2 individuals including 2 known (rs5891 [Val135Ile] in exon 3 and rs201977189 [Gly239Arg] in exon 5) and 2 novel (p57308-chr12_125292212 in intron 7 and p78334-chr12_125271186 in intron 10) variants ( Table 4 ). The carriers of rs5891 [Val-135Ile] variant were associated with higher apoB (β=5.8266; P=0.012) and lower TG (β=−0.2536; P=0.0306) levels than the wild type. Two individuals carrying the rs201977189 [Gly239Arg] variant had higher HDL-C levels than noncarriers (β=0.2937; P=0.0275). While 2 individuals carrying p57308-chr12_125292212 novel variant had lower levels of TG (β=−0.6937; P=0.015), and another 2 carrying the p78334-chr12_125271186 novel variant had higher levels of apoB (β=14.5804; P=0.0015) than the respective wild types. Three additional novel rare variants were observed in 1 individual each and each carrier had extreme lipid levels above the 95th percentile of the distribution compared with noncarriers.
Association of Haplotypes
Haplotype associations including all 69 variants were estimated by the fixed 4-variant-sliding window approach. A total of 23 significant haplotype windows associated with 4 lipid traits are presented in Table XII in the online-only Data Supplement (see detailed haplotype windows in Tables XIV and XV in the online-only Data Supplement). The most numbers of haplotype windows that yielded significant associations (global P<0.05) were observed for apoB (windows 21, 25-31, 44, 53-54; Figure 2 ). Of the 11 significant windows associated with apoB, the strongest signal was observed with window 28 (global P=0.0005). Of note, windows 25 to 31 contained the 3 FDR-significant apoB-associated variants in single-site analysis (rs2343394, rs4765615, and rs2278986), indicating that functional variants exist in this region.
Eight haplotype windows showed association with HDL-C (windows 12, 14-16, 60-63; Figure 2 ), and the most significant window was window 62 (global P=0.0034). Windows 14 to 16 contained rs11057844 and windows 60 to 63 contained rs701106; both variants (rs11057844 and rs701106) were nominally associated with HDL-C in single-site analysis. It seems that most of the effects in significant haplotype windows for apoB and HDL-C are partly derived from 6 of 7 variants that also showed significant association in single-site analysis. However, 5 significant windows for apoB (windows 21, 44, 53-54) and 1 for HDL-C (window 12) did not contain any associated variants from single-site analysis, indicating that overall haplotype approach yielded better information.
There were 3 (windows 1, 39-40) and 2 (windows 16-17) haplotype windows that showed significant association with LDL-C and TG, respectively (global P<0.05; Figure VC , VD in the online-only Data Supplement). None of the variants included in LDL-C and TG-associated haplotype windows had evidence of association with LDL-C or TG in single-site analysis. One haplotype window (window 16) was associated with both HDL-C (global P=0.0092) and TG (global P=0.0315).
The consecutive haplotype windows significantly associated with HDL-C and apoB (global P<0.05) revealed 2 regions associated with HDL-C (region 1: windows 14-16; region 4: windows 60-63), and 2 additional regions with apoB (region 2: windows 25-31; region 3: windows 53-54; Figure 2 ; Table XIII in the online-only Data Supplement). In region 1, the ACACGG haplotype (rs1229555, rs4765622, rs11057844, rs10846749, rs10744192, and rs10773107) showed the strongest significance associated with HDL-C. While, the GAGTCCG haplotype (rs838895, rs838893, rs797729, rs701106, rs10396214 [Arg484Trp in isoform 2], rs184715678, and p87210-chr12_125262310) was the best haplotype associated with HDL-C in region 4. Likewise, for apoB, the CCCTGGGCCG haplotype (rs11057830, rs199779577, rs73227571 [Tyr92Tyr], rs2343394, rs144194221, rs4765615, rs5891 [Val135Ile], rs2278986, p50432-chr12_125299088, and rs11057820) had the strongest signal in region 2. While, the rare haplotype (frequency <1%; rs201901986, rs34339961, rs2272310, p78334-chr12_125271186, and rs838897) yielded the most significant association with apoB in region 3.
Functional Prediction of Identified SCARB1 Variants
We determined the functionality of all 80 variants tested in this study (44 variants identified by sequencing, 32 HapMap tag-SNPs, and 4 additional SNPs with reported association from the literatures) using the RegulomeDB database (version 1.0, Stanford University, http://regulome.stanford.edu/index). 26 Of the total 80 variants, 71 (88.75%) had RegulomeDB scores ranging from 1f to 6: scores 1f to 2b (strong functional evidence), 6 variants; scores 3a to 3b (suggestive functional evidence), 3 variants; scores 4 to 6 (minimal functional evidence), 62 variants (Tables XVI and XVII in Seven variants that were found to be significantly associated with HDL-C or apoB showed only minimal functional evidence with RegulomeDB score of 5 ( Table 2) . Although rs838880, an HDL-C associated variant (P=0.025) was less likely to be functional (score 5), it was in strong LD (r 2 >0.90) with 3 other variants (rs838881, rs838882, and rs838884) identified by sequencing but not selected for genotyping ( Figure II in the online-only Data Supplement), of which rs838884 located in 3′ flanking had strong evidence of regulatory function based on RegulomeDB score of 2b. There were 6 HapMap tagged SNPs (bins 4, 12, 13) tightly linked to 3 significantly associated variants (r 2 ≥0.95; Figure I in the online-only Data Supplement), of which 5 (except rs838884) were less likely to have regulatory activities with scores 5 to 6 ( Table XVIII in the online-only Data Supplement).
Of the 11 rare novel variants, 9 (81.82%) were assigned RegulomeDB scores from 2b to 6 (Table VII in the onlineonly Data Supplement). Three novel variants are likely to be functional based on RegulomeDB scores of 2b (p50432-chr12_125299088, intron 3; p87210-chr12_125262310, exon 13-3′ untranslated region) and 3a (p64285-chr12_125285235, intron 7).
Discussion
The role of SCARB1 in facilitating HDL-C clearance through a selective uptake of cholesteryl ester from HDL-C to the liver and a HDL-C-mediated cellular flux of free cholesterol is well established. 10, 11 In addition to HDL-C, SCARB1 has highaffinity binding with apoB-containing lipoproteins 12, 13 and is involved in the clearance of non-HDL-C particles. 27 Hepatic overexpression of SCARB1 is associated with increased hepatic production of very low-density lipoprotein cholesterol (VLDL-C), 12, 28 leading to elevated levels of LDL-C, VLDL-C, and apoB. In contrast, SCARB1 knockout mice have significantly decreased levels of apoB-containing lipoproteins. 13 Because SCARB1 is involved in the metabolism of both HDL-C and apoB-containing lipid particles, the objective of this study was to resequence the SCARB1 gene in selected NHW individuals with extreme HDL-C levels to identify both common and LF/rare variants and then to examine the role of the identified variants with plasma HDL-C, LDL-C, TG, and apoB levels in the entire sample of 623 NHWs.
Resequencing of all 13 SCARB1 exons and exon-intron boundaries in selected individuals with extreme HDL-C levels identified 44 sequence variants, of which 40 were selected for genotyping. In addition, we selected 32 common HapMap tagSNPs covering the whole SCARB1 gene, plus 4 previously significantly associated variants for genotyping in the entire sample. Finally, 69 successfully genotyped variants (MAF≥5%, n=39; MAF<5%, n=30) were proceeded for association analyses in the total sample. Initial gene-based analysis including all 69 genotyped variants revealed a nominal association with apoB (P=0.0425) and a borderline association with HDL-C (P=0.132), reflecting the role of SCARB1 in apoB and HDL-C metabolism. Single-locus analysis revealed 3 nominally significant associations with HDL-C. The most significant association was observed with rs11057844 (P=0.0035; FDR=0.227) followed by rs701106 (P=0.0066; FDR=0.227). To our knowledge, these 2 are novel associations observed in this study. The third association was seen with rs838880 (P=0.025; FDR=0.457) that has previously been reported to be genome-wide significant in a large genome-wide association studies. 4 Similar to the reported genome-wide association study outcome, the minor allele of rs838880 was associated with increased HDL-C levels in our sample. These 3 variants seemed to be independently associated with HDL-C based on the weak correlation among them (mean r 2 <0.40, ranging from 0 to 0.37; Figure 1 ). Moreover, because all 3 variants have a minimal functional role based on RegulomeDB score of 5, it is not clear if they independently affect HDL-C or their effect is mediated through a yet to be identified functional variants. Furthermore, 7 of the 8 haplotype windows (windows 14-16 spanning within intron 1, 60-63 spanning between a part of intron 11 and a part of exon 13-3′ untranslated region) that showed significant association with HDL-C contained either rs11057844 or rs701106, implying that these 2 variants contributed to the observed haplotype effects. However, the remaining haplotype window (window 12) did not contain any HDL-C-associated variants in singlelocus analysis.
Three common SCARB1 variants (rs2343394, rs4765615, and rs2278986) demonstrated novel and FDR-significant associations with apoB where the minor alleles were associated with similar elevating effect sizes ( Table 2) . Although rs2343394 present in intron 2 and rs2278986 present in intron 3 were in strong LD (r 2 =0.94), together they showed moderate correlation (r 2 =0.46-0.48) with rs4765615 present in intron 2 (Figure 1 ). In addition to single-locus associations, haplotype analysis yielded association with apoB. Eleven haplotype windows were associated with apoB (windows 21, 25-31, 44, 53-54), of which 7 (windows 25-31 spanning between a part of intron 1 and a part of intron 4) contained ≥1 of the 3 FDRsignificant apoB-associated variants in single-site analysis (rs2343394, rs4765615, and rs2278986). Furthermore, a rare coding variant located in exon 4, rs5891 [Val135Ile], was also found to be associated with higher apoB levels (see Table 4 ), but this was not in LD with the 4 apoB-associated variants ( Figure VI in the online-only Data Supplement). Our data strongly indicate that functional variants exist in this region affecting apoB levels. Higher apoB levels are considered to be a risk factor for CHD, 29 and 1 of the 4 apoB-associated variants in our study (rs2343394) has previously been found to be associated with carotid intima-media thickness and incidence of CHD. 18 Furthermore, another apoB-associated variant (rs2278986) has also been found to be associated with lower SCARB1 protein levels. 30 Taken together, our findings in conjunction with the published data suggest that SCARB1 may have an apoB-mediated novel role in CHD.
Of the overall 23 haplotype windows that yielded significant association (global P<0.05), the majority were observed with HDL-C (n=8) and apoB (n=11; Table XII in the online-only Data Supplement). Moreover, the haplotype analysis identified 4 haplotype regions harboring 5 to 10 variants (Table XIII in the online-only Data Supplement) that were significantly associated with HDL-C (regions: 1, 4) and apoB (regions: 2, 3; Figure 2 ). Notably, 3 haplotype regions (regions: 1, 2, 4) contained 6 variants that yielded significant association in single-site analysis with HDL-C (rs11057844 and rs701106) or apoB (rs2343394, rs4765615, rs2278986, and rs11057820). Our data indicate that these 4 haplotype regions are good candidates for further deep resequencing to identify causal SCARB1 variants, because our current sequencing effort was mainly focused on coding regions and we may have missed regulatory functional variants present in introns.
